← Back to headlines
Pulmatrix reports GAAP EPS of -$0.29
Pulmatrix, a clinical-stage biopharmaceutical company, has reported a GAAP Earnings Per Share (EPS) of -$0.29.
13 Aug, 12:17 — 13 Aug, 12:17
Sources
Showing 1 of 1 sources
Pulmatrix, a clinical-stage biopharmaceutical company, has reported a GAAP Earnings Per Share (EPS) of -$0.29.
